<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0503233323
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                         Sodium Chloride 0.45% w/v bag
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        4.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        7.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PHARMACEUTICAL SOLUTIONS INDUSTRY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PHARMACEUTICAL SOLUTIONS INDUSTRY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 444]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05XA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sodium 0.45 Infusion is a solution of sodium chloride in water. Sodium chloride is a chemical</p><p>substance (often called &ldquo;salt&rdquo;) found in the blood. Sodium 0.45 Infusion is used to treat: &bull; a loss of</p><p>body water, for example after being sick or having diarrhoea (hypertonic extracellular dehydration) &bull; a</p><p>lower than normal volume of blood in the body (hypovolaemia) Sodium 0.45 infusion may also be used</p><p>to deliver or to dilute other medicines for infusion.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do NOT receive Sodium 0.45 Infusion if you are suffering from any of the following conditions &bull; lower</p><p>levels of chloride in the blood than normal (hypochloraemia) &bull; lower levels of sodium in the blood than</p><p>normal (hyponatraemia) &bull; severe kidney problems causing lower than normal or no urine production</p><p>(oliguria or anuria) &bull; higher than normal levels of water or sodium in the blood (fluid or sodium</p><p>retention) &bull; uncompensated heart failure. This is heart failure that is not adequately treated and</p><p>causes symptoms such as: &ndash; shortness of breath. &ndash; swelling of the ankles.&bull; build up of fluid under the</p><p>skin, affecting all parts of the body (general oedema) &bull; liver disease that causes fluid to build up within</p><p>the abdomen (ascitic cirrhosis) If a medicine has been added to Sodium 0.45 Infusion, the Package</p><p>Leaflet of the added medicine must be consulted to determine whether or not you can receive the</p><p>solution.</p><p><strong>Warnings and precautions</strong></p><p>Please tell your doctor if you have or have had any of the following medical conditions: &bull; any type of</p><p>heart disease or poor heart function &bull; poor kidney function &bull; respiratory failure (lung disease)(special</p><p>monitoring may be required in the above conditions) &bull; raised production of the hormone aldosterone</p><p>(aldosteronism) when there is a larger volume of blood in the blood vessels than there should be</p><p>(hypervolaemia) &bull; high blood pressure (hypertension) &bull; high blood pressure during pregnancy</p><p>(preeclampsia) &bull; any other condition associated with sodium and fluid retention (when the body retains</p><p>too much sodium or water), such as treatment with steroids (See also below &ldquo;Taking other medicines&rdquo;)</p><p>&bull; if you have a condition that could cause high levels of vasopressin, a hormone regulating fluid in your</p><p>body. You may have too much vasopressin in your body because, for example: - you have had a</p><p>sudden and serious illness - you are in pain - you have had surgery - you have infections, burns or</p><p>brain disease - you have diseases linked to your heart, liver, kidneys or central nervous system</p><p>- because you are taking certain medicines (see also below &ldquo;Other medicines and Sodium 0.45</p><p>Infusion&rdquo;). This may increase the risk of low levels of sodium in your blood and can lead to headache,</p><p>nausea, seizures, lethargy, coma, swelling of the brain and death. Brain swelling increases the risk of</p><p>death and brain damage. People who are at higher risk of brain swelling are: - children - women</p><p>(particularly if you are of a fertile age) - people who have problems with their brain fluid levels, for</p><p>example, because of meningitis, bleeding in the skull or a brain injury. Some patients are at higher risk</p><p>for having or developing a too low sodium concentration in your blood (hyponatraemia). In general this</p><p>applies to: &bull; young and old people &bull; women &bull; anyone with a condition such as low levels of oxygen in</p><p>your blood (hypoxemia) &bull; drinking a lot due to a dry mouth (psychogenic polydipsia) &bull; if you have</p><p>recently been operated on &bull; if you have certain diseases of the nervous system &bull; if you are taking</p><p>certain antiepileptic and psychiatric medicines.</p><p><strong>Other medicines and Sodium 0.45 Infusion</strong></p><p>Please tell your doctor or nurse if you are taking, have recently taken or might take any other</p><p>medicines. It is particularly important that you inform your doctor if you are taking: &bull; corticosteroids</p><p>(anti-inflammatory medicines).&bull; carbenoxolone (an anti-inflammatory medicine used to treat stomach</p><p>ulcers) These medicines can cause the body to accumulate sodium and water, leading to:</p><p>&ndash; tissue swelling due to fluid collection under the skin (oedema) &ndash; high blood pressure (hypertension) &bull;</p><p>Lithium (used to treat psychiatric illness) &bull; Some medicines act on the hormone vasopressin.These</p><p>may include: - anti-diabetic medication (chlorpropamide) - cholesterol medicine (clofibrate)</p><p>- some cancer drugs (vincristine, ifosfamide, cyclophosphamide) - selective serotonin reuptake</p><p>inhibitors (used to treat depression) - antipsychotics - opioids for severe pain relief - medicines for</p><p>pain and/or inflammation (also known as NSAIDs) - medicines that imitate or strengthen the effects of</p><p>vasopressin such as desmopressin (used to treat increased thirst and urination), terlipressin (used to</p><p>treat bleeding of the gullet) and oxytocin (used to induce labour) - anti-epileptic medication</p><p>(carbamazepine and oxcarbazepine) - diuretics (water tablets).</p><p>Sodium 0.45 Infusion with food and drink</p><p>You should ask your doctor about what you can eat or drink.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask</p><p>your doctor or nurse for advice before taking this medicine. If another medicine is to be added to your</p><p>solution for infusion during pregnancy or breast-feeding you should: &bull; consult your doctor &bull; read the</p><p>Package Leaflet of the medicine that is to be added.</p><p><strong>Driving and using machines</strong></p><p>Ask your doctor or nurse for advice before driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sodium 0.45 Infusion will be given to you by a doctor or nurse. Your doctor will decide on how much</p><p>you need and when it is to be given. This will depend on your age, weight, condition, the reason for</p><p>treatment and whether or not the infusion is being used to deliver or dilute another medicine. The</p><p>amount you are given may also be affected by other treatments you are receiving. You should NOT be</p><p>given Sodium 0.45 Infusion if there are particles floating in the solution or if the pack is damaged in</p><p>any way. Sodium 0.45 Infusion will usually be given to you through a plastic tube attached to a needle</p><p>in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use</p><p>another method to give you the medicine. Before and during the infusion, your doctor will monitor: &bull;</p><p>the amount of fluid in your body &bull; the acidity of your blood and urine &bull; the amount of electrolytes in</p><p>your body (particularly sodium, in patients with high level of vasopressin, or are taking other medicines</p><p>which increase the effect of vasopressin). This is especially important for children as they have a</p><p>limited ability to regulate fluids and electrolytes. Any unused solution should be thrown away. You</p><p>should NOT be given an infusion of Sodium 0.45 Infusion from a bag that has been partly used.</p><p><strong>If you receive more Sodium 0.45 Infusion than you should</strong></p><p>If you are given too much Sodium 0.45 Infusion (overinfusion), or it is given too fast, this may lead to</p><p>the following symptoms: &bull; build up of water in the body (oedema) &bull; too much water in the blood</p><p>(haemodilution) &bull; heart problems &bull; acidification of the blood (acidosis), leading to tiredness, confusion,</p><p>lethargy and increased breathing rate If Sodium 0.45 Infusion is given too fast when you have higher</p><p>than normal levels of salts in the blood (hypertonicity), swelling of the brain (brain oedema) is possible,</p><p>especially if you often have higher than normal levels of sodium in the blood (hypernatraemia). If you</p><p>develop any of these symptoms you must inform your doctor immediately. Your infusion will be</p><p>stopped and you will be given treatment depending on the symptoms. If a medicine has been added to</p><p>your Sodium 0.45 Infusion before over-infusion occurs, that medicine may also cause symptoms.</p><p>If you stop receiving your Sodium 0.45 Infusion</p><p>Your doctor will decide when to stop giving you this infusion. If you have any further questions on the</p><p>use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. &bull; too much</p><p>fluid in the body (overhydration) which may lead to more frequent urination (polyuria) &bull; changes in the</p><p>concentrations of the chemicals in the blood (electrolyte disturbances) &bull; heart failure, if you suffer from</p><p>heart disease or fluid in the lungs (pulmonary oedema) &bull; low levels of sodium in the blood that may be</p><p>acquired during hospitalization (nosocomial hyponatraemia) and related neurological disorder (acute</p><p>hyponatraemic encephalopathy). Hyponatraemia can lead to irreversible brain injury and death due to</p><p>cerebral oedema/swelling (see also section 2 &ldquo;Warnings and precautions&rdquo;). The side effects that may</p><p>occur due to the administration technique include: &bull; fever (febrile response) &bull; infection at the site of</p><p>infusion &bull; local pain or reaction (redness or swelling at the site of infusion) &bull; irritation and inflammation</p><p>of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and</p><p>swelling along the path of the vein into which the solution is infused &bull; the formation of a blood clot</p><p>(venous thrombosis) at the site of infusion, which causes pain, swelling or redness in the area of the</p><p>clot &bull; escape of the infusion solution into the tissues around the vein (extravasation). This can damage</p><p>the tissues and cause scarring. Other side effects noted with similar products (sodium chloride</p><p>containing solutions) include: &bull; acidification of the blood (hyperchloraemic metabolic acidosis) &bull;</p><p>reactions with the following symptoms have been reported: - hives (urticaria) which may be localised to</p><p>a part of the body or widespread - fever (pyrexia) - skin rash - chills - itching (pruritus) - decreased</p><p>blood pressure &bull; Other infusion site reactions: - hives at the infusion site. If a medicine has been added</p><p>to the solution for infusion, the added medicine may also cause side effects. These side effects will</p><p>depend on the medicine that has been added. You should read the Package Leaflet of the added</p><p>medicine for a list of possible symptoms.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse.</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children. Do not store above 30&deg;C.</p><p>Sodium 0.45 Infusion does not require special storage conditions. Sodium 0.45 Infusion should NOT</p><p>be given to you after the expiry date which is stated on the bag after EXP. The expiry date refers to the</p><p>last day of that month. You should not be given Sodium 0.45 Infusion, if there are particles floating in</p><p>the solution or if the unit is damaged</p><p>in any way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Sodium Chloride 0.45% w/v Intravenous Infusion BP contains</strong></p><p>&bull; The active substance is sodium chloride. 1 Litre of solution contain 4.50 g of sodium chloride &bull; The</p><p>other ingredient is water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicine is a solution for infusion (for administration by a vein drip). It is a clear colorless sterile
solution of sodium chloride in water. It is supplied in Non PVC Bags containing 250 ml, 500 ml and
1000ml.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmaceutical Solutions Industry Ltd.</p><p>Industrial Estate, Phase-2,</p><p>Road No. 208, Str. - 203</p><p>P O Box 17476 Jeddah 21484</p><p>Western Province-Saudi Arabia</p><p>Phone: +966-12-6361383</p><p>FAX: +966-12-6379460</p><p>Website: http://www.psiltd.com</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&bull; Saudi Arabia:</p><p>The National Pharmacovigilance Centre (NPC):</p><p>Fax: +966-11-205-7662</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p>Other GCC States:</p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ھو محلول من كلوريد الصوديوم في الماء. كلوريد الصوديوم مادة كیميائية (تسمى غالبًا &quot;ملح&quot;) توجد في الدم.<br />يستخدم تسريب الصوديوم ۰٫٤٥ لعلاج: &bull; فقدان ماء الجسم ، على سبيل المثال بعد المرض أو الإسهال<br />(الجفاف خارج الخلية مفرط التوتر) &bull; انخفاض حجم الدم في الجسم عن المعدل الطبيعي (نقص حجم الدم) يمكن<br />أيضًا استخدام محلول ۰٫٤٥ للصوديوم من أجل توصيل أو تخفيف أدوية أخرى للتسريب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول محلول الصودیوم إذا كنت تعاني من أي من الحالات التالیة &bull; انخفاض مستویات الكلورید في الدم<br />عن المعدل الطبیعي (نقص كلورید الدم) &bull; انخفاض مستویات الصودیوم في الدم عن المعدل الطبیعي (نقص<br />صودیوم الدم) &bull; مشاكل حادة في الكلى تسبب انخفاضًا عن الطبیعي أو عدم إنتاج البول (قلة البول أو انقطاع<br />البول) &bull; مستویات أعلى من المعتاد من الماء أو الصودیوم في الدم (احتباس السوائل أو الصودیوم) &bull; قصور<br />القلب غیر المعوض. ھذا ھو قصور القلب الذي لا یعالج بشكل كاف ویسبب أعراض مثل: - ضیق التنفس. -<br />تورم الكاحلین. &bull; تراكم السوائل تحت الجلد ، مما یؤثر على جمیع أجزاء الجسم (الوذمة العامة) &bull; أمراض<br />الكبد التي تسبب تراكم السوائل داخل البطن (تلیف الكبد الاستسقائي) إذا تم إضافة دواء إلى ۰٫٤٥ ٪ كلورید<br />الصودیوم یجب استشارة نشرة الحزمة الخاصة بالدواء المضاف لتحدید ما إذا كان بإمكانك تلقي المحلول أم<br />لا.<br />المحاذیر والإحتیاطات.<br />یرجى إخبار طبیبك إذا كنت تعاني أو كنت تعاني من أي من الحالات الطبیة التالية: &bull; أي نوع من أمراض<br />القلب أو ضعف وظائف القلب &bull; ضعف وظائف الكلى &bull; فشل الجهاز التنفسي (مرض الرئة) (قد تكون ھناك<br />حاجة إلى مراقبة خاصة في الحالات المذكورة أعلاه) &bull; زیادة إنتاج ھرمون الألدوستيرون (الألدوستیرونیة)<br />عندما يكون حجم الدم في الأوعیة الدمویة أكبر مما ينبغي (فرط حجم الدم) &bull; ارتفاع ضغط الدم (ارتفاع<br />ضغط الدم) &bull; ارتفاع ضغط الدم أثناء الحمل (تسمم الحمل) &bull; أي حالة أخرى مرتبطة الصوديوم واحتباس<br />السوائل (عندما يحتفظ الجسم بكمیة كبیرة من الصوديوم أو الماء) ، مثل العلاج بالستیرويدات (انظر أيضًا<br />أدناه &quot;تناول أدویة أخرى&quot;)<br />&bull; إذا كنت تعاني من حالة مرضية يمكن أن تسبب مستويات عالیة من ھرمون فاسوبريسین ، وھو ھرمون<br />ینظم السوائل في جسمك. قد یكون لدیك الكثیر من الفازوبریسین في جسمك بسبب ، على سبیل المثال: - لدیك<br />مرض مفاجئ وخطیر - كنت تعاني من الألم - خضعت لعملیة جراحیة - لدیك عدوى أو حروق أو أمراض<br />دماغیة - لدیك أمراض مرتبطة بقلبك والكبد والكلى أو الجھاز العصبي المركزي<br />- لأنك تتناول أدویة معینة (انظر أیضًا أدناه &quot;أدویة أخرى وتسریب الصودیوم ۰٫٤٥ &quot;). قد یزید ھذا من<br />خطر انخفاض مستویات الصودیوم في الدم ويمكن أن یؤدي إلى الصداع والغثيان والنوبات والخمول<br />والغیبوبة وتورم الدماغ والموت. يزيد تورم الدماغ من خطر الموت وتلف الدماغ. الأشخاص الأكثر عرضة<br />لتورم الدماغ ھم: - الأطفال - النساء (خاصة إذا كنت في سن الخصوبة) - الأشخاص الذین یعانون من<br />مشاكل في مستویات سوائل الدماغ ، على سبیل المثال ، بسبب التھاب السحایا أو نزیف في الجمجمة أو<br />الدماغ إصابة. یكون بعض المرضى أكثر عرضة لخطر الإصابة بتركیز صودیوم منخفض جدًا أو تطویره<br />في الدم (نقص صودیوم الدم). بشكل عام ، ینطبق ھذا على: &bull; الشباب وكبار السن &bull; النساء &bull; أي شخص<br />یعاني من حالة مثل انخفاض مستویات الأكسجین في الدم (نقص تأكسج الدم) &bull; شرب الكثیر بسبب جفاف الفم<br />(العطاش النفسي المنشأ) &bull; إذا كنت قد أجریت عملیة جراحیة مؤخرًا في &bull; إذا كنت تعاني من أمراض معینة<br />في الجھاز العصبي &bull; إذا كنت تتناول بعض الأدویة المضادة للصرع والأدویة النفسیة.<br />أخذ أو استخدام أدویة أخرى<br />یرجى إخبار طبیبك أو ممرضتك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدویة أخرى. من المھم<br />بشكل خاص أن تبلغ طبیبك إذا كنت تتناول: &bull; الكورتیكوستیرویدات (أدویة مضادة للالتھابات). &bull;<br />كاربینوكسولون (دواء مضاد للالتھابات یستخدم لعلاج قرحة المعدة) یمكن أن تتسبب ھذه الأدویة في تراكم<br />الصودیوم والماء في الجسم ، مما یؤدي إلى: - تورم الأنسجة بسبب تجمع السوائل تحت الجلد (الوذمة) -<br />ارتفاع ضغط الدم (ارتفاع ضغط الدم) &bull; اللیثیوم (یستخدم لعلاج الأمراض النفسیة) &bull; تعمل بعض الأدویة<br />على ھرمون فاسوبریسین ، وقد تشمل ھذه الأدویة: - الأدویة المضادة للسكري (كلوربروبامید) - دواء<br />الكولیسترول (كلوفیبرات) - بعض أدویة السرطان (فینكریستین ، إفوسفامید ، سیكلوفوسفامید) - مثبطات<br />امتصاص السیروتونین الانتقائیة (تستخدم لعلاج الاكتئاب) - مضادات الذھان - المواد الأفیونیة لتسكین الآلام<br />الشدیدة - أدویة الألم و / أو الالتھاب (المعروفة أیضًا باسم مضادات الالتھاب غیر الستیروئیدیة) - الأدویة<br />التي تقلد أو تقوي آثار فازوبریسین مثل دیسموبریسین (یستخدم لعلاج زیادة العطش والتبول) ، تیرلیبریسین<br />(یستخدم لعلاج نزیف المريء) والأوكسیتوسین (یستخدم للحث على المخاض) - الأدویة المضادة للصرع<br />(كاربامازیبین وأوكسكاربازیبین) - مدرات البول (أقراص الماء) ).<br />۰٫٤٥ ٪ كلورید الصودیوم مع الطعام والشراب<br />یجب أن تسأل طبیبك عما یمكنك أن تأكلھ أو تشربھ.<br />الحمل والرضاعة<br />إذا كنت حاملاً أو مرضعة ، تعتقدین أنك حامل أو تخططین لإنجاب طفل ، اسألي طبیبك أو ممرضتك<br />للحصول على المشورة قبل تناول ھذا الدواء. في حالة إضافة دواء آخر إلى المحلول الخاص بك من أجل<br />التسریب أثناء الحمل أو الإرضاع ، یجب علیك: &bull; استشارة الطبیب &bull; قراءة نشرة العبوة الخاصة بالدواء<br />المراد إضافتھ.<br />القیادة واستعمال الآلات<br />اسأل طبیبك أو ممرضتك للحصول على المشورة قبل القیادة أو استخدام الآلات</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>یتم إعطاؤك محلول ۰٫٤٥ ٪ كلورید الصودیوم من قبل الطبیب أو الممرضة. سیقرر طبیبك مقدار ما تحتاجھ<br />ومتى یجب إعطاؤه. سیعتمد ھذا على عمرك ووزنك وحالتك وسبب العلاج وما إذا كان یتم استخدام التسریب<br />لتوصیل دواء آخر أو تخفیفھ. قد یتأثر المبلغ الذي یتم إعطاؤه أیضًا بالعلاجات الأخرى التي تتلقاھا. یجب<br />عدم إعطائك محلول ۰٫٤٥ ٪ كلورید الصودیوم إذا كانت ھناك جزیئات تطفو في المحلول أو في حالة تلف<br />العبوة بأي شكل من الأشكال. عادة ما یتم إعطاؤك محلول ۰٫٤٥ ٪ كلورید الصودیوم من خلال أنبوب<br />بلاستیكي متصل بإبرة في الورید. عادة ما یتم استخدام ورید في ذراعك لإعطائك التسریب. ومع ذلك ، قد<br />یستخدم طبیبك طریقة أخرى لإعطائك الدواء. قبل وأثناء التسریب ، سیراقب طبیبك: &bull; كمیة السوائل في<br />جسمك &bull; حموضة الدم والبول &bull; كمیة الشوارد في جسمك (لا سیما الصودیوم ، في المرضى الذین یعانون من<br />ارتفاع مستوى الفازوبریسین ، أو الذین یتناولون الأدویة الأخرى التي تزید من تأثیر الفازوبریسین). ھذا مھم<br />بشكل خاص للأطفال لأن لدیھم قدرة محدودة على تنظیم السوائل والشوارد. یجب التخلص من أي محلول<br />غیر مستخدم. لا ینبغي أن تحصل على محلول ۰٫٤٥ ٪ كلورید الصودیوم من كیس تم استخدامھ جزئیًا.<br />إذا تلقیت محلول ۰٫٤٥ ٪ كلورید الصودیوم أكثر مما ینبغي<br />إذا تم إعطاؤك الكثیر من محلول ۰٫٤٥ ٪ كلورید الصودیوم (تسریب مفرط) ، أو تم إعطاؤه بسرعة كبیرة ،<br />فقد یؤدي ذلك إلى الأعراض التالیة: &bull; تراكم الماء في الجسم (الوذمة) &bull; وجود الكثیر من الماء في الدم<br />(تخفیف الدم) &bull; مشاكل في القلب &bull; تحمض الدم (الحماض) ، مما یؤدي إلى التعب والارتباك والخمول وزیادة<br />معدل التنفس. (وذمة الدماغ) ممكنة ، خاصةً إذا كان لدیك غالبًا مستویات أعلى من الطبیعي من الصودیوم<br />في الدم (فرط صودیوم الدم). إذا ظھرت لدیك أي من ھذه الأعراض ، یجب علیك إبلاغ طبیبك على الفور.<br />٪ سیتم إیقاف التسریب وسیتم إعطاؤك العلاج حسب الأعراض. إذا تمت إضافة دواء إلى محلول ۰٫٤٥<br />كلورید الصودیوم قبل حدوث الإفراط في التسریب ، فقد یتسبب ھذا الدواء أیضًا في ظھور أعراض.<br />إذا توقفت عن تلقي محلول ۰٫٤٥ ٪ كلورید الصودیوم<br />سیقرر طبیبك متى یتوقف عن إعطائك ھذا التسریب. إذا كان لدیك أي أسئلة أخرى حول استخدام ھذا الدواء<br />، اسأل طبیبك أو ممرضتك..</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة ، یمكن أن یسبب ھذا الدواء آثارًا جانبیة ، على الرغم من عدم حدوثھا لدى الجمیع. &bull; كثرة<br />السوائل في الجسم (الجفاف) الذي قد یؤدي إلى كثرة التبول (التبول) &bull; تغیرات في تركیزات المواد الكیمیائیة<br />في الدم (اضطرابات الكھارل) &bull; قصور القلب ، إذا كنت تعاني من أمراض القلب أو وجود سوائل في الرئتین<br />(الوذمة الرئویة) &bull; انخفاض مستویات الصودیوم في الدم التي قد تكون<br />المكتسبة أثناء الاستشفاء (نقص صودیوم الدم في المستشفیات) والاضطراب العصبي المرتبط (اعتلال الدماغ<br />الحاد بنقص صودیوم الدم). یمكن أن یؤدي نقص صودیوم الدم إلى إصابة دماغیة لا رجعة فیھا وموت بسبب<br />الوذمة الدماغیة / التورم (انظر أیضًا القسم ۲ &quot;التحذیرات والاحتیاطات&quot;). تشمل الآثار الجانبیة التي قد<br />تحدث بسبب تقنیة الإعطاء ما یلي: &bull; حمى (استجابة حمویة) &bull; عدوى في موقع التسریب &bull; ألم موضعي أو<br />رد فعل (احمرار أو تورم في موقع التسریب) &bull; تھیج والتھاب في الورید یملأ المحلول (التھاب الورید). یمكن<br />أن یسبب ھذا احمرارًا أو ألمًا أو حرقة وتورمًا على طول مسار الورید الذي یتم ضخ المحلول فیھ &bull; تكوین<br />جلطة دمویة (تجلط وریدي) في موقع التسریب ، مما یسبب ألمًا أو تورمًا أو احمرارًا في منطقة الحقن.<br />الجلطة &bull; تسرب محلول التسریب إلى الأنسجة حول الورید (تسرب). ھذا یمكن أن یتلف الأنسجة ویسبب<br />ندبات. تشمل الآثار الجانبیة الأخرى التي لوحظت مع منتجات مماثلة (محالیل تحتوي على كلورید<br />الصودیوم) ما یلي: &bull; تحمض الدم (الحماض الاستقلابي بفرط كلورید الدم) &bull;<br />تم الإبلاغ عن تفاعلات مع الأعراض التالیة: - خلایا النحل (الشرى) التي قد تكون موضعیة في جزء من<br />الجسم أو منتشرة - حمى (حمى) - طفح جلدي - قشعریرة - حكة (حكة) - انخفاض ضغط الدم &bull; ردود فعل<br />أخرى في موقع التسریب : - خلایا في موقع الحقن. إذا تمت إضافة دواء إلى المحلول للتسریب ، فقد یتسبب<br />الدواء المضاف أیضًا في حدوث آثار جانبیة. ستعتمد ھذه الآثار الجانبیة على الدواء المضاف. یجب علیك<br />قراءة نشرة الحزمة الخاصة بالدواء المضاف للحصول على قائمة بالأعراض المحتملة.<br />الإبلاغ عن الآثار الجانبیة<br />إذا حصلت على أي آثار جانبیة ، فتحدث إلى طبیبك أو الصیدلي أو الممرض.<br />عن طریق الإبلاغ عن الآثار الجانبیة ، یمكنك المساعدة في توفیر المزید من المعلومات حول سلامة ھذا<br />الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احفظ ھذا الدواء بعیدًا عن رؤیة ومتناول أیدي الأطفال. لاتخزن في درجة حرارة فوق ۳۰ درجة مئویة.<br />٪ لا یتطلب محلول ۰٫٤٥ ٪ كلورید الصودیوم شروط تخزین خاصة. لا ینبغي أن تعطى محلول ۰٫٤٥<br />یشیر تاریخ انتھاء الصلاحیة .EXP كلورید الصودیوم بعد تاریخ انتھاء الصلاحیة المدون على الكیس بعد<br />إلى الیوم الأخیر من نفس الشھر. یجب عدم إعطائك محلول ۰٫٤٥ ٪ كلورید الصودیوم إذا كانت ھناك<br />جزیئات تطفو في المحلول أو في حالة تلف الوحدة بأي طریقة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما یحتوي كلورید الصودیوم ۰٫٤٥ ٪ للحقن الوریدي:<br />المادة الفعالة ھي كلورید الصودیوم. ۱۰۰۰ مل من محلول یحتوي على ٤٫٥۰ غرام من كلورید الصودیوم<br />العنصر الآخر ھو الماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ھذا الدواء ھو محلول للتسریب (للإعطاء عن طریق الورید بالتنقیط).<br />محلول معقم عدیم اللون واضح.<br />یتم توفیره في أكیاس بلاستیكیة باحجام : ۲٥۰ مل و ٥۰۰ مل و ۱۰۰۰ مل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مصنع المحالیل الطبیة.</p><p dir="RTL">العنوان:المنطقة الصناعیة، المرحلة الثانیة.</p><p dir="RTL">طریق رقم ۲۰۸ ، شارع ۲۰۳</p><p dir="RTL">. صندوق برید ۱۷٤۷٦ جدة ۲۱٤۸٤</p><p dir="RTL">المنطقة الغربیة</p><p dir="RTL">المملكة العربیة السعودیة</p><p dir="RTL">+۹٦٦-۱۲- الھاتف: ٦۳٦۱۳۸۳</p><p dir="RTL">+۹٦٦-۱۲- الفاكس: ٦۳۷۹٤٦۰</p><p dir="RTL">http://www.psiltd.com: الموقع الالكتروني</p><p dir="RTL">تمت الموافقة على ھذه النشرة بتاریخ ینایر ۲۰۲۲</p><p dir="RTL">&nbsp;</p><p dir="RTL">للإبلاغ عن أي أعراض جانبیة:</p><p dir="RTL">المملكة العربیة السعودیة</p><p dir="RTL">المركز الوطني للتیقظ الدوائي:</p><p dir="RTL">+ فاكس: ۹٦٦۱۱۲۰٥۷٦٦۲</p><p dir="RTL">مركز الإتصال الموحد للهيئة العامه للغذاء والدواء -السعودیة : ۱۹۹۹۹</p><p dir="RTL">npc.drug@sfda.gov.sa البرید الإلكتروني</p><p dir="RTL">https://ade.sfda.gov.sa: الموقع الإلكتروني</p><p dir="RTL">دول الخلیج الأخرى:</p><p dir="RTL">الرجاء الاتصال بالمؤسسات والھیئات الوطنیة في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride 0.45% Solution for Infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride: 4.5 g/l
Each ml contains 4.5 mg sodium chloride.
Na+ Clmmol/
l 77 77
mEq/l 77 77
154 mOsm/l (approx.)
pH: 4.5 – 7.0
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride 0.45% Solution for Infusion is indicated for the treatment of hypertonic<br />extracellular dehydration or hypovolaemia in cases where the intake of fluids and electrolytes by<br />normal routes is not possible.<br />It can also be used as a vehicle or diluent of compatible medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults, Adolescents and Children:<br />Fluid balance, serum electrolytes and acid-base balance should be monitored before and during<br />administration, with particular attention to serum sodium in patients with increased non-osmotic<br />vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in<br />patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquired<br />hyponatraemia (see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly<br />important for hypotonic fluids.<br />Sodium Chloride 0.45% Solution for Infusion has a tonicity of 154 mOsm/l (approx.)<br />The infusion rate and volume depend on age, weight, clinical condition (e.g. burns, surgery,<br />head-injury, infections) and concomitant therapy should be determined by the consulting<br />physician experienced in intravenous fluid therapy (see sections 4.4. and 4.8).<br />Recommended dosage:</p><p>- For adults, older people and adolescents: 500 ml to 3 litres/24h,<br />- For babies and children: 20 to 100 ml per 24 h and per kg of body weight, depending on the age<br />and the total body mass.<br />The recommended dosage when used as a vehicle or diluent ranges from 50 to 250 ml per dose<br />of medicinal product to be administered.<br />Administration rate:<br />The infusion rate depends on the patient clinical conditions. It is usually:<br />40 ml/kg/24h for adults, older people and adolescents,<br />- 5 ml/kg/h in average for paediatric patients but the value varies with age:<br />- 6-8 ml/kg/h for infants,<br />- 4-6 ml/kg/h for toddlers,<br />- 2-4 ml/kg/h for schoolchildren.<br />Note: - Infants and toddlers: age ranges from about 28 days to 23 months (a toddler is an infant who can<br />walk),<br />- Children and schoolchildren: age ranges from about 2 years to 11 years.<br />When Sodium Chloride 0.45% Solution for Infusion is used as a diluent for injectable<br />preparations of other medicinal products, the infusion rate will also be dictated by the nature and<br />the dose regimen of the prescribed medicinal products.<br />Method of Administration:<br />The solution is for administration by intravenous infusion through a sterile and non-pyrogenic<br />administration set, using aseptic technique. The equipment should be primed with the solution to<br />prevent air entering the system.<br />The product should be inspected visually for particulate matter and discoloration prior to<br />administration. Do not administer unless solution is clear, free from visible particles and the seal<br />is intact.<br />Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of<br />the solution. Administer immediately following the insertion of infusion set.<br />Do not connect flexible plastic containers in series in order to avoid air embolism due to possible<br />residual air contained in the primary container. Pressurizing intravenous solutions contained in<br />flexible plastic containers to increase flow rates can result in air embolism if the residual air in<br />the container is not fully evacuated prior to administration. Use of a vented intravenous<br />administration set with the vent in the open position could result in air embolism. Vented<br />intravenous administration sets with the vent in the open position should not be used with<br />flexible plastic containers.<br />Additives may be introduced before infusion or during infusion through the injection site.<br />Adding other medication or using an incorrect administration technique might cause the<br />appearance of fever reactions due to the possible introduction of pyrogens. If an adverse event<br />occurs the patient evaluated and appropriate countermeasures started. If needed the infusion</p><p>should be stopped.<br />For information on incompatibilities and preparation of the product with additives, please see<br />sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The solution is contra-indicated in patient presenting:
- Hyponatraemia, hypochloraemia,
- Extracellular hyperhydration or hypervolaemia,
Severe renal insufficiency (with oliguria/anuria),
Fluid and sodium retention,
Uncompensated cardiac failure,
General oedema and ascitic cirrhosis.
The contra-indications related to the added medicinal product should be considered.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrolyte balance<br />Hyponatraemia/Hypernatraemia<br />The infusion of solutions with sodium concentrations &lt;0.9% may result in hyponatraemia.<br />High volume infusion must be used under specific monitoring in patients with cardiac or<br />pulmonary failure and in patients with non-osmotic vasopressin release (including SIADH), due<br />to the risk of hospital-acquired hyponatraemia (see below).<br />Hyponatraemia<br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, post-operative stress,<br />infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients<br />exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia<br />upon infusion of hypotonic fluids.<br />Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral oedema)<br />characterized by headache, nausea, seizures, lethargy, and vomiting. The risk for hyponatraemia<br />is increased, for example,<br />&bull; In children<br />&bull; In elderly patients<br />&bull; In women<br />&bull; In patients with hypoxemia<br />&bull; In patients with underlying central nervous system disease<br />&bull; Postoperatively<br />&bull; In persons with psychogenic polydipsia in patients treated with medications that increase the<br />risk of hyponatraemia (such as certain antiepileptic and psychotropic medications).<br />Patients with cerebral oedema are at particular risk of severe, irreversible and life-threatening<br />brain injury. Children, women in the fertile age and patients with reduced cerebral compliance<br />(e.g. meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at particular risk<br />of the severe and life-threatening brain swelling caused by acute hyponatraemia.<br />Acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.<br />Hyponatraemia should be corrected at a calculated rate to prevent hyponatraemic<br />encephalopathy.<br />Rapid correction of hyponatraemia and hypernatremia is potentially dangerous (risk of serious<br />neurologic complications). Rapidly correcting hypernatremia once adaptation has occurred may<br />lead to cerebral oedema, potentially resulting in seizures, permanent brain damage, or death.<br />Dosage, rate, and duration of administration should be determined by a physician experienced in</p><p>intravenous fluid therapy.<br />Fluid balance/renal function<br />Use in patients with moderate renal impairment<br />The product should be administered with particular caution to patients with moderate renal<br />impairment. In such patients administration of Sodium Chloride 0.45% Solution for Infusion<br />may result in sodium retention.<br />Risk of fluid and/or solute overload and electrolyte disturbances<br />Depending on the volume and rate of infusion, intravenous administration of Sodium Chloride<br />0.45% Solution for Infusion can cause<br />&bull; Fluid and/or solute overload resulting in over hydration/hypervolemia and, for example,<br />congested states, including central and peripheral oedema.<br />&bull; Clinically relevant electrolyte disturbances and acid-base imbalance.<br />In general; the risk of dilutional states is inversely proportional to the electrolyte concentrations<br />in the solution and additions. The risk of solute overload causing congested states is directly<br />proportional to the electrolyte concentration in the solution and its additions.</p><p>Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes<br />in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral<br />therapy or whenever the condition of the patient or the rate of administration warrants such<br />evaluation.<br />Use in patients at risk for sodium retention, fluid overload and oedema<br />Sodium Chloride 0.45% Solution for Infusion should be used with particular caution, if at all, in<br />patients with or at risk for:<br />&bull; Hypervolemia<br />&bull; Conditions that may cause sodium retention, fluid overload and oedema (central and<br />peripheral), such as patients with<br />- primary hyperaldosteronism,<br />- secondary hyperaldosteronism associated with, for example,<br />- hypertension,<br />- congestive heart failure,<br />- liver disease (including cirrhosis),<br />- renal disease (including renal artery stenosis, nephrosclerosis) or<br />- pre-eclampsia.<br />Medications that may increase the risk of sodium and fluid retention, such as corticosteroids.<br />Infusion reactions<br />Symptoms of unknown aetiology which can appear to be hypersensitivity reactions have been<br />reported very rarely in association with parenteral infusion of Sodium Chloride. These have been<br />characterized as hypotension, pyrexia, tremor, chills, urticaria, rash and pruritus. Stop the<br />infusion immediately if signs or symptoms of these reactions develop. Appropriate therapeutic<br />countermeasures should be instituted as clinically indicated.<br />Specific patient groups<br />The consulting physician should be experienced in this product&#39;s use and safety in these special<br />populations that are especially sensitive to rapid changes in serum sodium levels.<br />Rapid correction of hyponatraemia and hypernatremia is potentially dangerous (risk of serious<br />neurologic complications). see section &ldquo;Hyponatraemia/hypernatraemia&rdquo; above.<br />Paediatric population<br />Plasma electrolyte concentrations should be closely monitored in the paediatric population as this<br />population may have impaired ability to regulate fluids and electrolytes. Repeated infusions of<br />sodium chloride should only be given after determination of serum sodium level.<br />The infusion of hypotonic fluids together with the non-osmotic secretion of ADH may result in<br />hyponatraemia. Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral<br />oedema and death, therefore acute symptomatic hyponatraemic encephalopathy is considered a<br />medical emergency.<br />Geriatric population<br />In older people, the risk for hyponatraemia is increased. When selecting the type of infusion<br />solution and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are<br />generally more likely to have cardiac, renal, hepatic, and other diseases or concomitant drug<br />therapy.</p><p>Other warnings<br />Osmolarity<br />Sodium Chloride 0.45% Solution for Infusion is hypotonic with an osmolarity of approximately<br />154 mOsmol/L.<br />Administration with blood products<br />Do not mix or administer Sodium Chloride 0.45% Solution for Infusion through the same<br />administration set with whole blood or cellular blood components.<br />During long-term infusion, the doctor can decide to give you an appropriate nutritive supply.<br />As with all parenteral solutions, compatibilities should be checked when additives are used (see<br />section 6.2).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interaction related to the presence of sodium:<br />Corticoids/Steroids and carbenoxolone, which are associated with the retention of sodium and<br />water (with oedema and hypertension), see section 4.4 special warnings and precautions for use.<br />Drugs leading to an increased vasopressin effect:<br />The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free<br />water excretion and may increase the risk of hospital acquired hyponatraemia following<br />inappropriately balanced treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).<br />&bull; Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate, carbamazepine,<br />vincristine, selective serotonin reuptake inhibitors, 3.4-methylenedioxy-N-methamphetamine,<br />ifosfamide, antipsychotics, and narcotics<br />&bull; Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, and<br />cyclophosphamide<br />&bull; Vasopressin analogues include: Desmopressin, oxytocin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include diuretics in general<br />and antiepileptics such as oxcarbazepine.<br />Caution is advised in patients treated with lithium. Renal sodium and lithium clearance may be<br />decreased in the presence of hyponatraemia. Administration of Sodium Chloride 0.45% Solution<br />for Infusion may result in increased lithium levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no adequate data from the use Sodium Chloride 0.45% Solution for Infusion in<br />pregnant or lactating women. The physician should carefully consider the potential risks and<br />benefits for each specific patient before administering Sodium Chloride 0.45% Solution.<br />Sodium Chloride 0.45% Solution for Infusion should be administrated with special caution for<br />pregnant women during labour particularly as to serum-sodium if administered in combination<br />with oxytocin (see section 4.4, 4.5 and 4.8).<br />When a medicinal product is added, the nature of the drug and its use during pregnancy and<br />lactation have to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of Sodium Chloride 0.45% Solution for Infusion on the<br />ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects have been reported to have occurred during or following<br />infusion of Sodium Chloride 0.45% Solution for Infusion.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:201px">System Organ Class</td><td style="width:297px">Symptoms (LLT terms MedDRA)</td></tr><tr><td style="width:201px">&nbsp;</td><td style="width:297px">Overhydration* (associated or not with polyuria) in patients<br />with cardiac disorder or pulmonary oedema<br />Asymptomatic electrolyte disturbance<br />Hyponatraemia<br />Hospital acquired hyponatraemia**</td></tr><tr><td style="width:201px">Nervous system disorders</td><td style="width:297px">Acute hyponatraemic encephalopathy**</td></tr><tr><td style="width:201px">Cardiac disorders</td><td style="width:297px">Heart failure in patients with cardiac disorder or pulmonary<br />oedema</td></tr><tr><td style="width:201px">Vascular disorders</td><td style="width:297px">Thrombophlebitis*<br />Venous thrombosis*</td></tr><tr><td style="width:201px">General disorders and administration site<br />conditions</td><td style="width:297px">Fever*<br />Injection site pain*<br />Injection site reaction*<br />Injection site phlebitis*<br />Injection site irritation*<br />Injection site infection*<br />Extravasation*</td></tr></tbody></table><p>The frequency of the adverse drug reactions listed in this section cannot be estimated from the<br />available data<br />* Adverse reactions associated with the technique of administration<br />**Hospital acquired hyponatraemia may cause irreversible brain injury and death, due to<br />development of acute hyponatraemic encephalopathy, frequency unknown (see sections 4.2. 4.4,<br />4.5).<br />The following adverse reactions have not been reported with this product but may occur:<br />&bull; Hyperchloraemic metabolic acidosis<br />&bull; Infusion reactions, including hypotension, tremor, chills, urticaria, rash, and pruritus.</p><p>Adverse reactions may be associated to the medicinal products added to the solution; the nature<br />of the additive will determine the likelihood of any other undesirable effects.<br />If an adverse event occurs the patient should be evaluated and appropriate countermeasures<br />started, if needed the infusion should be stopped<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important.<br />It allows continued monitoring of the benefit/risk balance of the medicinal product.<br />To report any side effect(s):<br />Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa<br />Other GCC States:<br />Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume of Sodium Chloride 0.45% Solution for Infusion may lead to:<br />&bull; hypo- and hypernatremia (which can lead to CNS manifestations, including seizures, coma,<br />cerebral oedema and death) and<br />&bull; sodium overload (which can lead to central and/or peripheral oedema).<br />See also section 4.4.<br />Excessive administration of chloride salts may cause a loss of bicarbonate with an acidifying<br />effect.<br />When Sodium Chloride 0.45% Solution for Infusion is used as a diluent for injectable<br />preparations of other medicinal products, the signs and symptoms of over infusion will be related<br />to the nature of the additives being used.<br />In the event of accidental over infusion, treatment should be discontinued and the patient should<br />be observed for the appropriate signs and symptoms related to the drug administered. The<br />relevant and supportive measures should be provided as necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group &ldquo;Electrolyte solutions&rdquo;, ATC code B05XA03.<br />Sodium Chloride 0.45% Solution for Infusion is a hypotonic solution, with an approximate<br />osmolarity of 154 mOsm/l.<br />The pharmacodynamic properties of the solution are those of the sodium and chloride ions in<br />maintaining the fluid and electrolyte balance. Ions, such as sodium, circulate through the cell<br />membrane, using various mechanisms of transport, among which is the sodium pump (Na-KATPase).<br />Sodium plays an important role in neurotransmission and cardiac electrophysiology,<br />and also in renal function.<br />Chloride is mainly an extracellular anion. Intracellular chloride is in high concentration in red<br />blood cells and gastric mucosa. Reabsorption of chloride follows reabsorption of sodium.<br />When medication is added to Sodium Chloride 0.45% Solution for Infusion, the overall<br />pharmacodynamics of the solution will depend on the nature of the medicinal product used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium and Chloride are mainly distributed in blood and extracellular compartiments (Na+: 142<br />mmol/l &ndash; Cl-: 103 mmol/l).<br />Sodium is predominantly excreted by the kidney with a renal reabsorption.<br />Small amounts of sodium are lost in the faeces and sweat at the skin level.<br />When medication is added to Sodium Chloride 0.45% Solution for Infusion, the overall<br />pharmacokinetics of the solution will depend on the nature of the medicinal product used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of this solution for infusion in animals are not relevant since its<br />constituents are physiological components of animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibility of the medicinal product to be added to the solution in Viaflo container must be<br />assessed before addition. Those additives known to be incompatible should not be used.<br />In the absence of compatibility studies, this solution must not be mixed with other medicinal<br />productsSee section 6.6 for further instructions on the use of the product with additives</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years for Non-PVC Bags
4 years for Plastic Bottles
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>250 ml, 500 ml and 1000ml Non-PVC Bags.<br />250 ml, 500 ml and 1000 ml Plastic bottle (polyethylene).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Please see section 4.2 for information regarding the method of administration.<br />Before adding a drug, verify it is soluble and stable in water at the pH range of the Sodium<br />Chloride 0.45% Solution for Infusion (pH 4.5 to 7.0). Additives may be introduced before<br />infusion or during infusion through the injection site.<br />It is the responsibility of the healthcare professional to judge the incompatibility of an additive<br />medication with the Sodium Chloride 0.45% Solution for Infusion, by checking for eventual<br />colour change and/or eventual appearance of precipitate, insoluble complexes or crystals. The<br />instruction for use of the medicinal product to be added must be consulted.<br />When additive is used, verify isotonicity prior to parenteral administration. Thorough and careful<br />aseptic mixing of any additive is mandatory. Solutions containing additives should be used<br />immediately and not stored.<br />Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.<br />Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of<br />the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                To report any side effect(s):

For Saudi Arabia:

The National Pharmacovigilance and Drug Safety Centre (NPC)

* Fax: +966-11-205-7662

* Reporting hotline: 19999.

* E-mail: npc.drug@sfda.gov.sa

* Website: www.sfda.gov.sa/npc

Other GCC States:
Please contact the relevant competent authority
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/ 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>